Page last updated: 2024-10-26

valproic acid and Leishmaniasis

valproic acid has been researched along with Leishmaniasis in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sinha, M1
Jagadeesan, R1
Kumar, N1
Saha, S1
Kothandan, G1
Kumar, D1

Other Studies

1 other study available for valproic acid and Leishmaniasis

ArticleYear
In-silico studies on Myo inositol-1-phosphate synthase of
    Journal of biomolecular structure & dynamics, 2022, Volume: 40, Issue:8

    Topics: Animals; Inositol; Leishmania donovani; Leishmaniasis; Ligands; Mammals; Molecular Dynamics Simulati

2022